Major risk of blood transfusion in hemolytic anemia patients

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 4, 2011, Pages 280-284

  Omar, Nagla ^a   Salama, Khaled ^a   Adolf, Sonya ^b   El Saeed, Gamila S M ^c   Abdel Ghaffar, Nagwa ^d   Ezzat, Nivin ^d  

^a CAIRO UNIVERSITY   (Egypt)

^b Pediatrics Department   (Egypt)

^c Medical Biochemistry Department   (Egypt)

^d NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

thalassemia major; hepatitis B; hepatitis C; HIV; seroprevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CELL COUNT; BLOOD TRANSFUSION; CHILD; FERRITIN BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; THALASSEMIA; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANEMIA, HEMOLYTIC; ANTIBODIES; BLOOD CELL COUNT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; EGYPT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FERRITINS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THALASSEMIA; TRANSAMINASES;

EID: 79955964874     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283451255     Document Type: Article

References (32)

1. Taher AT, Otrock ZK, Uthma I, Cappellini MD. Thalassemia and hypercoagulability. Blood 2008; 22:283-292.
2. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99:36-43.
3. Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. J Paediatr Child Health 2001; 37:564-566. (Pubitemid 34042952)
4. Weatherall DJ, Clegg JB. ?Management and prognosis? in ?the thalassaemia syndromes?, 4th ed. Oxford, UK: Blackwell Scientific Publications; 2001.
5. Prati D, Zanella A, Farma E, De Mattei C, Bosoni P, Zappa M, et al. The Cooley care cooperative group: a multicenter prospective study on the risk of acquiring liver disease in anti-HCV negative patients affected from homozygous b-thalassaemia. Blood 1998; 92:3460-3464. (Pubitemid 28492359)
6. Lim Y, Yoon S. An Experience of the use of antiHBC and antHBs for blood donor screening tests at a tertiary hospital blood center in Korea. Korean J Lab Med 2009; 29:59-65.
7. Wright M, Goldin R, Hellier S, Knapp S, Frodsham A, Hennig B, et al. Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut 2003; 52:1206-1210. (Pubitemid 36877437)
8. Poujol-Robert A, Böelle PY, Poupon R, Robert A. Activated protein C resistance (factor V Leiden) as a risk factor for cirrhosis in chronic hepatitis C patients. Hepatology 2004; 39:1174-1175. (Pubitemid 38428958)
9. Hurie MBE, Mast J, Davis P. Horizontal transmission of hepatitis B virus infection to US born children of Hmong refugees. Pediatrics 1992; 89:269-273.
10. McHutchison JG, Person JL, Govindarajan S, Valinluck B, Gore T, Lee SR, et al. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology 1992; 15:19-25.
11. Ecker B, Vollenhofer S, Bares T, Schalkhammer T, Schinkinger M, Pittner F. Overexpression and purification of a recombinant chimeric HIV type2/HIV type I envelope peptide and application in an accelerated immunobased HIV type 1/2 antibody detection system (AIBs): a new rapid serological screening assay. AIDS Res Hum Retroviruses 1996; 12:1081-1091. (Pubitemid 26317412)
12. Berg T, Meller AR, Platz KP, Hohne M, Bechstein WO, Hopf M, Schriier E. Viremia early after orthotopic liver transplantation indicates extra hepatic tissues as the predominant site of virus C replication. Hepatology 1999; 29:245-249. (Pubitemid 29024009)
13. Abu El-Hassan AM, El-Beshlawy A, Kaddah N, Mostafa A. The frequency of blood born viruses esp. (HBV,HCV and HIV) among Egyptian thalassemic children. New Egypt J Med 1993; 8:135-138.
14. Zaki ES, Gorg L, Chowdhury R, Ahssan I. Prevalence of hepatitis D in patients infected with hepatitis B. J Trop Pediatr 2003; 49:371-374.
15. El-Gilany AH, El-Fedawy S. Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt. East Mediterr Health J 2006; (6):742-748. (Pubitemid 46358268)
16. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder L, et al. The role of parentral antischistosomal therapy in the spread of hepatitis in Egypt. Lancet 2000; 355:887-891. (Pubitemid 30137669)
17. Sibal A, Mishra D, Arora M. Hepatitis C in childhood. J Indian Med Assoc 2002; 100:93-98. (Pubitemid 34606425)
18. Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Gamil F, Madkour S, et al. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 2001; 33(1):248-253. (Pubitemid 32016908)
19. Medhat A, Nafeh M, Shehata M, Mikhail N, Swify Y, Abdel-Hamid M, et al. Hepatitis in a community in upper Egypt. Cross-sectional survey. Am J Trop Med Hyg 2002; 63:236-241. (Pubitemid 32537556)
20. El-Raziky MS, El-Hawary M, Esmat G, Abouzied AM, El-Koofy N, Mohsen N, et al. Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children. World J Gastroenterol 2007; 13:1828-1832. (Pubitemid 46706017)
21. El-Raziky MS, El-Hawary M, El-Koofy N, Okasha S, Kotb M, Salama K, et al. Hepatitis C virus infection in Egyptian children: single centre experience. J Viral Hepat 2004; 11:471-476. (Pubitemid 39336231)
22. Mishra D, Pensi T. Transfusion associated hepatitis C in multi-transfused thalassemic children. Indian Pediatr 2004; 41:287-288. (Pubitemid 38387498)
23. Choudhury N, Saraswat S, Naveed M. Serological monitoring of thalassemia major patients for transfusion associated viral infections. Indian J Med Res 1998; 107:263-268. (Pubitemid 28379647)
24. Ghaderi AA, Agahi MH. High prevalence of anti-HCV and HTLV-1 antibodies in thalassemia-major patients of southern Iran. Ir J Med Sci 1996; 2-1:60-62.
25. Fuzae L, Aboolbacker KC, Al-Saleh Q. Beta-thalassaemia major in Kuwait. J Trop Pediatr 1998; 44:311-312.
26. de Montalembert M, Costagliola DG, Lefrere JJ, Cornu G, Lombardo T, Cosentino S, et al. Prevalence of markers for human immunodeficiency virus types 1 and 2, human T-lymphotropic virus type I, cytomegalovirus, and hepatitis B and C virus in multiply transfused thalassemia patients. The French Study Group on Thalassemia. Transfusion 1992; 32:509-512.
27. Jamal R, Fadzillah G, Zulkifli SZ, Yasmin M. Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: results from a thalassemia day care center in Malaysia. Southeast Asian J Trop Med Public Health 1998; 29(4):792-794.
28. Garrido Serrano A, Guerrero Igea FJ, Lepe Jimé nez JA, Palomo Gil S, Grilo Reina A. Hepatitis C virus infection, increased serum ferritin and hyperinsulinemia. Rev Esp Enferm Dig 2001; 93:639-648.
29. Li C, Chik K, Lan C, To K, Yu S, Lee V, et al. Liver disease in transfusion dependent thalassemia major. Arch Dis Child 2002; 86:344-347. (Pubitemid 34478230)
30. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deepvein thrombosis. Lancet 1995; 345:152-154.
31. Kraaijenhagen RA, in?t Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, Buller HR. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000; 83:5-9. (Pubitemid 30045467)
32. Kamphuisen PW, Eikenboom JCJ, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001; 21:731-738. (Pubitemid 32448761)